The estimated Net Worth of Christopher G Roberts is at least $85.4 Million dollars as of 29 September 2017. Christopher Roberts owns over 25,934 units of Resmed stock worth over $56,739,314 and over the last 22 years Christopher sold RMD stock worth over $28,680,920.
Christopher has made over 43 trades of the Resmed stock since 2003, according to the Form 4 filled with the SEC. Most recently Christopher exercised 25,934 units of RMD stock worth $1,010,907 on 29 September 2017.
The largest trade Christopher's ever made was exercising 79,500 units of Resmed stock on 4 February 2015 worth over $1,542,300. On average, Christopher trades about 18,162 units every 82 days since 2003. As of 29 September 2017 Christopher still owns at least 224,337 units of Resmed stock.
You can see the complete history of Christopher Roberts stock trades at the bottom of the page.
Christopher's mailing address filed with the SEC is , , , , .
Over the last 22 years, insiders at Resmed have traded over $250,830,262 worth of Resmed stock and bought 10,000 units worth $424,500 . The most active insiders traders include Peter C Farrell, Gary W Pace, and David Pendarvis. On average, Resmed executives and independent directors trade stock every 7 days with the average trade being worth of $3,005,701. The most recent stock trade was executed by Brett Sandercock on 9 September 2024, trading 1,000 units of RMD stock currently worth $246,420.
at resmed (nyse: rmd, asx: rmd) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. our cloud-connected medical devices transform care for people with sleep apnea, copd and other chronic diseases. our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. by enabling better care, we improve quality of life, reduce the impact of chronic disease and lower costs for consumers and healthcare systems in more than 120 countries.
Resmed executives and other stock owners filed with the SEC include: